ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection
Clinical trial NCT03183141 · COMPLETED
Trial details
- NCT number
- NCT03183141
- Sponsor
- Seres Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-23
- Primary completion
- 2022-04-29
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.